A Randomized, Double-Blind, Placebo-Controlled, Two Dose-Arm, Parallel Study of the Safety and Effectiveness of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) for the Treatment of Mild-To-Moderate Alzheimer's Disease

Grant

Date/time Interval

  • June 22, 2010 - June 21, 2014
  • Total Award Amount

  • 306430.00
  • Direct Costs

  • 243200.00
  • Sponsor Award Id

  • 160701
  • Contributor

  • Roberson, Erik   Investigator